PSMB9 and cancer: In another example of this approach, Lin et al. evaluated the efficacy of a multi-epitope, cancer PBV consisting of predicted TH, TC, and B cell epitopes of the LMP2 protein (a TAA found in EBV-associated cancers) (213).